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Synopsis  
 Rotator cuff calcific tendinopathy (RCCT) is a common finding that accounts 
for about 7% of patients with shoulder pain. There are numerous theories on the 
pathogenesis of RCCT, all dealing with tendon injury and then subsequent calcium 
deposition that can then lead to tendonitis, subacromial impingement, and bursitis. 
The diagnosis is confirmed with x-ray, MRI or ultrasound. There are numerous 
conservative treatment options available and most patients can be managed 
successfully without surgical intervention. Nonsteroidal Anti-inflammatory Drugs 
(NSAIDs) and modalities are commonly used to manage pain and inflammation, 
whereas physical therapy can help improve scapular mechanics and decrease 
dynamic impingement of the calcific tendon in the subacromial space. Patients with 
ongoing pain may benefit from extracorporal shock wave therapy (ESWT) or 
injection therapy into the subacromial bursa or calcific tendon itself. Ultrasound-
guided needle aspiration and lavage techniques have been shown to provide 
excellent long-term improvement in pain and function in patients with RCCT. 
 
 
 
 
 
Key Points 
 Rotator cuff calcific tendinopathy is a common asymptomatic finding on 
imaging studies that accounts for shoulder pain approximately 7% of the 
time 
 A majority of patients are managed conservatively with a combination of 
NSAIDs, modalities, physical therapy, and injection therapy 
 The goal of physical therapy is to improve scapular mechanics and decrease 
subacromial impingement secondary to rotator cuff calcific tendinopathy 
 Ultrasound guided needle aspiration and lavage of calcium deposits in the 
rotator cuff tendons has been shown to decrease the size of deposits and 
improve pain and function on a long-term basis 
Introduction 
 Rotator cuff disease is a common cause of shoulder pain. The differential 
diagnosis of rotator cuff disease includes tendinitis, tendinopathy, subacromial 
impingement, partial and full thickness tendon tears, and calcific tendinopathy. 
Although calcific tendinopathy is a common incidental finding on imaging studies, it 
can also be a cause of significant shoulder pain and disability. The supraspinatus 
tendon is most commonly involved which can lead to significant subacromial 
impingement and limit activities at or above shoulder level. Like many other rotator 
cuff problems, a majority of patients respond well to relative rest, NSAIDs, physical 
therapy, and subacromial bursa injections with corticosteroids. There is growing 
interest and use of ultrasound guided injection procedures in musculoskeletal 
medicine. One novel technique for the treatment of RCCT involves advancing a 
larger gauge needle under live sonography into the calcium deposit, fragmenting it 
and aspirating its contents. This technique has been shown to provide excellent 
long-term pain relief and may be a good alternative to surgical intervention.  
Epidemiology 
There have been a number of studies on the epidemiology of RCCT. One of 
the most famous of these studies was done by Bosworth in 1941 who looked at 
5,061 office employees and found the prevalence of calcium deposits in the rotator 
cuff to be 2.7% on fluoroscopic examination.1 A number of other studies have 
reported prevalence rates ranging from 2.7% to 22%, mostly affecting people 
ranging from 30-50 years of age.1-3 It is often an asymptomatic finding on imaging 
studies. However, when considering people with shoulder pain, RCCT is a finding 
6.8% of the time.4  When one shoulder is affected, the other shoulder will also be 
affected 14% of the time. 7 Similar to other rotator cuff pathology, the supraspinatus 
tendon is most likely to be affected.3  
People with sedentary lifestyles experience a higher risk of developing 
RCCT.4 Ischemic heart disease, hypertension, diabetes and thyroid disease are 
known associated medical conditions that seem to predispose patients to 
developing calcific tendinopathy for reasons not well understood.5 There is a known 
correlation with calcific tendinopathy and endocrine disorders. These patients have 
an earlier onset of symptoms, a longer disease course, and ultimately undergo 
surgery more frequently than people that do not have these conditions.6 
Interestingly, RCCT is rarely associated with metabolic disorders related to calcium 
or phosphorus.7  
Pathophysiology 
The mechanism of the pathogenesis of calcific tendinopathy has remained 
elusive. There are several competing theories. It has been suggested that one of the 
reasons the pathogenesis remains unknown is that biopsies obtained are done near 
the end of the natural history of the disease.8,9 The four theories on the pathogenesis 
of calcific tendinopathy that will be discussed in this paper include degenerative 
calcification, reactive calcification, endochondral ossification and chondral 
metaplasia (Table 1).  
In degenerative calcification it has been proposed that tendon fibers 
deteriorate over time. It is believed that aging tenocytes become progressively more 
damaged with time as a result of decreased vascular flow and tendon fibers become 
hypocellular and eventually undergo necrosis from the damage.3,10-12 As a result, 
intracellular calcium builds within the tenocytes in the form of psamomma bodies 
during the beginning phases of calcification. This in turn becomes larger over time 
until there are macroscopic areas of calcification that will be apparent on imaging 
and possibly symptomatic in affected patients.3,8,12 
Reactive calcification proposes the cause of calcification is a multi-stage 
process beginning with tenocyte metaplasia which leads to calcification and 
ultimately a cell-mediated inflammatory reaction.9 Uhtoff et al proposed dividing 
the process into 3 main stages; precalcific, calcific, and post calcific (Table 2).9 In the 
precalcific stage the tenocytes undergo metaplasia into fibrocartilaginous tissue. 
This acts as a substrate for calcium deposition, which is believed to be mediated by 
chondrocytes3,9. The calcific stage is when actual calcium deposition occurs in the 
tendon and the body’s subsequent reaction to a calcified tendon. Uhtoff et al further 
subdivides the calcific stage into the formative and resorptive phases. In the 
formative phase, calcium crystals deposit into the affected tissue, which is mediated 
by the chondrocytes of the metaplastic fibrocartilagenous tissue, that eventually 
combine into larger areas of calcified tissue. Uhtoff further comments that if surgery 
is done during this stage of the disease the calcified areas will be chalky and need to 
be ‘scooped’ out.3 The resorptive phase begins after a varying period of dormancy in 
the disease course. The affected area develops ‘vascular channels’ where 
macrophages phagocytose and eliminate the calcium.3,9 Finally, the postcalcific 
phase describes the process where fibroblasts in granulation tissue remodel the 
affected tissue following calcium removal.3,9  
Another mechanism proposed by Benjamin et al, who studied Achilles 
tendons of rats, suggested that endochondral ossification of fibrocartilage is the 
pathogenesis of calcific tendinopathy.8,13 Again, fibrocartilage first develops in 
affected sites through the process of metaplasia. The fibrocartilage then develops 
vascular flow from underlying bone marrow. As the fibrocartilage becomes 
increasingly vascular, deposits of calcium form.13 What develops is essentially a 
bone spur in the tendon tissue.8,13 An important note, is that through this process no 
inflammatory reaction was seen to take place.13 Unfortunately, Benjamin et al did 
not report on the process of resorption and changes that take place in the rat 
tendons.  
The fourth mechanism discussed here is that of chondral metaplasia. Rui et al 
believes the calcification of tenocytes is a result of erroneous differentiation of 
tendon stem cells into bone cells.14 Hashimoto et al showed that injection of BMP-2 
into tendons produced ectopic bone formation in the tendon suggesting tendon 
stem cells were responsive to proteins thought to induce bone growth.8,15 The exact 
mechanism by which tendon stem cells differentiate themselves incorrectly into 
bone is not clear at this point.  
To complement the discussion, it has been proposed that there are genetic 
components that predispose certain populations to developing calcific 
tendinopathy.5 It should also be mentioned again that there are a number of 
endocrine and vascular disorders that are associated with calcific tendinopathy. 
However, it is not clear how they affect the natural history of the disease.  
Although the exact mechanism of the pathophysiology remains elusive, there 
are a few important points to take into consideration: 
 There are a number of things that likely contribute to the development of calcific 
tendinopathy   
 There are a number of medical conditions that can predispose a person to this 
condition 
 There may be a genetic component and familial predisposition  
It is tempting to think there is some sort of injury that first occurs to the tendon 
cells, whether it’s an acute clinically apparent injury or a series of subclinical 
microtraumas over the span of several years. Certainly, something must occur to 
induce metaplasia of the tenocytes that ultimately lead to the development of 
calcific tendinopathy. Furthermore, it is unclear if the calcification and resorption 
process is a part of normal healing that takes place in an injured tendon.  
Clinical presentation 
Calcific tendinopathy of the shoulder may present in a number of different 
ways, however the main complaint when patients are symptomatic will be pain. As 
previously discussed, epidemiologic studies have shown that many cases of calcific 
tendinopathy of the shoulder will be asymptomatic or an incidental finding on 
imaging studies. However, Bosworth et al reported that 34-45% of patients with 
rotator cuff calcifications were found to be symptomatic.1 
A good way to look at rotator cuff calcific tendinopathy, and its typical 
natural history, is that the disease progresses through 3 stages: the pre-calcification 
stage, the calcification stage, which includes the formative and resorptive phases, 
and the post-calcific stage (Table 2).  
Often times the pain is worse in acute presentations than in chronic 
presentations.2,7 In some chronic forms there may be periods where patients are 
asymptomatic and a relapsing remitting pattern will be observed.2 Uhtoff et al and 
Speed et al have both commented that it is during the resorptive stage that patients 
are most likely to develop symptoms and this was attributed to the process of 
resorption of calcium itself.3,4 When osteolysis of the greater tuberosity is observed 
in calcific tendinopathy of the shoulder, it has been reported that there is an 
association with worse outcomes, more pain, more functional impairment and less 
success with surgery.16 In most cases, the pain and other symptoms will be self-
limited and the natural history of the disease is for pain to improve over time 
without the need for aggressive interventions. 
History and Physical Examination 
A complete history is important when evaluating a patient with shoulder 
pain. Questions to ask relate to pain with overhead activities, night pain, a history of 
trauma, or sports participation. It is also helpful to ask about numbness, tingling, 
burning, or weakness, as this may suggest a cervical radiculopathy or brachial 
plexopathy. A medical history significant for diabetes or thyroid disease may 
increase suspicion for calcific tendinopathy. 
A thorough physical examination is also important when evaluating a patient 
with shoulder pain. The examination should begin with inspection and palpation of 
the painful shoulder. Active and passive range of motion of the shoulder should also 
be assessed. Manual muscle testing should be done to assess for weakness that may 
be related to pain inhibition, a rotator cuff tear, or neurological injury. Sensation and 
reflexes should also be assessed if nerve damage is suspected. Finally, provocative 
tests should be done.  
Tests classically used to assess shoulder pain related to subacromial 
impingement include the Hawkin’s impingement test, Neer’s sign test, and Yocum’s 
test. These maneuvers all have in common the idea that when performed correctly 
the subacromial space is compressed. For all of the above impingement tests, 
reproducible pain with the maneuver is considered a positive sign.  In the Hawkin’s 
test, the shoulder is passively flexed to 90 degrees and internally rotated by the 
examiner. In the Yocum’s test, the patient places their hand on the contralateral 
shoulder and elevates their elbow without elevating the shoulder in the process.  
The Neer’s sign test is performed by passively forward flexing an internally rotated 
shoulder.17 
Occasionally, a patient will have constitutional symptoms of fever and 
malaise.4 In these patients, elevated inflammatory markers may be found on blood 
work such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and 
serum white blood count (WBC).4 In these patients it is important to consider septic 
arthritis, gout, and pseudogout.  Ultimately, to make the diagnosis of calcific 
tendinopathy of the rotator cuff, imaging studies will be needed.  
Imaging studies 
Plain films are often adequate to diagnose calcific tendinopathy of the rotator 
cuff.   Anteroposterior, outlet view, internal rotation, and external rotation views are 
routinely ordered (Fig.1). Magnetic resonance imaging (MRI) can be a useful adjunct 
study to see if there is an associated rotator cuff tear and to evaluate for suspected 
osteolysis of the greater tuberosity. In addition, MRI has a distinct advantage for 
evaluation of the glenoid labrum, subcortical bone, and deep soft tissues when 
compared to other imaging modalities.  
Ultrasound has become another useful tool for evaluating sources of 
shoulder pain, with comparable sensitivities to magnetic resonance imaging when 
performed by a skilled ultrasonographer.18,19 Additionally, ultrasound allows the 
ultrasonographer to perform a dynamic evaluation to assess for subacromial 
impingement. Another advantage of ultrasound is that the resolution from the 
transducer is better than that from magnetic resonance imaging, on the order of 200 
µm with current technology.19  
More specifically, ultrasound has been shown to be an effective tool to 
diagnose calcific tendinopathy and has been shown to have the ability to identify 
even small calcific lesions.20 In addition, two separate studies showed that a positive 
Doppler signal within calcific deposits correlated with a patient having pain.21,22 
Clinically, this could help determine if the calcification is the cause of a patient’s pain 
or just an incidental finding.  
On ultrasound, the calcium deposits will usually have a hyperechoic 
appearance often with acoustic shadowing noticeable on exam (Fig. 2).23 The 
calcification may also appear isoechoic, and an amorphous calcification will replace 
the normal fibrillar appearance of a tendon.23,24 Typically, the calcifications will be 
found on ultrasound exam along the fibrillar appearing tendon fibers. Frequently, 
they appear linearly along the tendon fiber, but may at times appear globular or 
amorphous if the calcification is not well-formed yet.23,24 Ultrasound may also pick 
up cortical bony erosions, which may help with prognosis.  
Treatment Options 
Medications 
Non-steroidal anti-inflammatory drugs (NSAIDs) are a common treatment 
for many painful conditions. This class of medications inhibits cyclooxygenase-1 and 
cyclooxygenase-2 (COX-1 and COX-2) enzymes, which are important in the 
inflammatory cascade that produces prostaglandins and thromboxanes. They are 
frequently used to help treat pain associated with subacromial bursitis, rotator cuff 
tendonitis and other causes of shoulder pain, including calcific tendinopathy.  
Although no studies have focused on what medication regimen is optimal, it is 
reasonable to treat patients symptomatically with NSAIDs.  
Caution should always be used when prescribing NSAIDs to patients with a 
history of gastrointestinal (GI) or cardiac disease. Upper GI complications, including 
bleeding, have been found to be increased using NSAIDs versus placebo.25 NSAIDs, 
as a class, have been associated with increased risk of vascular events as well, 
including myocardial infarction and stroke.25-27    
Yokoyama et al looked at using histamine blockade to reduce the symptoms 
associated with calcific tendinopathy. The rationale for using this class of 
medication was the decrease in serum calcium seen in patients with 
hyperparathyroidism treated with a histamine blocker. Sixteen patients who failed 
conservative treatment were treated with cimetidine for 3 months. Results showed 
reduced VAS scores, decreased impairment of shoulder movement, and radiologic 
evidence of decreased calcium deposit size compared to pre-treatment.28  Although 
the mechanism is unclear, in this small sample size, cimetidine appears to have 
benefited these patients. 
Other medications to consider include Tramadol (Ultram) or rarely short-
acting narcotics. These may be considered in patients who are having difficulty 
sleeping secondary to moderate to severe pain. 
Modalities 
Multiple modalities have been utilized in the treatment of RCCT, including 
iontophoresis, therapeutic ultrasound, and extracorporal shock wave therapy. 
Acetic acid iontophoresis (AAI) was first described in the treatment of calcific 
tendinosis in 1955.29 More recently, multiple randomized controlled trials have 
been performed to analyze the effectiveness of this modality. The theory is that 
using acetic acid will acidify the environment around the calcium depositions.  Since 
most calcium crystals are made of hydroxyapatite crystals, the depositions should, 
in theory, dissolve in this environment.  Iontophoresis is used to help direct the 
medication to deeper tissues. Two recent studies failed to show improvement with 
AAI in the treatment of RCCT. One study compared AAI with no treatment, and 
found improvement in the area and density of the calcium deposits of both groups at 
the end of the study compared to pre-treatment, but no difference between 
groups.30 Similarly, Leduc et al found improvements in pain, range of motion and 
number of calcium deposits from the beginning of the study to after the treatment 
period, both in those receiving AAI and those receiving sham treatment.31 Time, 
with or without physiotherapy, appeared to improve patients’ symptoms in these 
studies.  Larger studies may be needed to show benefit, but at this time it is difficult 
to recommend the use of AAI in the treatment of RCCT. 
Therapeutic ultrasound 
Therapeutic ultrasound may be used for painful musculoskeletal disorders, 
and was looked at specifically in treating RCCT in one study in the New England 
Journal of Medicine in 1999. Investigators treated patients with pulsed therapeutic 
ultrasound for 24 sessions over 6 weeks and found both decreased pain and 
improved quality of life when compared to sham ultrasound.32 These results were 
significant at the end of the study, but the effects were no longer statistically 
significant at the 9-month follow up. 
Extracorporal shock wave therapy 
Extracorporal shock wave therapy (ESWT) is a modality that is often used to 
break up urologic calcium stones and has recently been investigated in RCCT.  One 
group in Italy found a decrease in pain, increase in function and associated decrease 
in calcium deposit size after four treatments with ESWT compared to sham 
therapy.33 These findings were significant immediately after treatment and at one 
and six months post-treatment.  
Another study looked at long-term results for patients who received ESWT 
for RCCT. In this study group, most of the patients received a single treatment (n= 
27), while others received two (n=9) or three (n=3) treatment sessions. At 6-month 
follow-up, the treatment group had decreased pain, increased power, motion and 
activity when compared to the control group.34 Calcium deposit size was also noted 
to be decreased in the study group, with no difference in the control group.  When 
following these patients 2 years post-treatment, 90.9% of patients had significant, if 
not complete, improvement in shoulder symptoms.  This study, however, had a very 
small control group and patients were not blinded to treatment group.  
Rebuzzi compared ESWT to arthroscopic surgery, and found no difference 
between groups in functional improvement or pain reduction.35 No other studies 
that we are aware of directly compare non-operative treatments to each other, or to 
surgery. 
ESWT is often not covered by insurance companies and the cost to the 
patient may range from  $100-$1000 per treatment session. It is often noted to be a 
painful procedure for patients. 
Physical Therapy 
The conservative management of shoulder pain related to RCCT usually 
involves a formal physical therapy program. Range of motion exercises and 
improving scapular mechanics can benefit patients with calcific tendinopathy. There 
are no available studies that outline a specific therapy protocol for patients with 
RCCT. However, there are many studies that look at subacromial impingement, a 
common sequelae of RCCT. 
Scapular dyskinesis, abnormal position and movement of the scapula, can 
contribute to shoulder pain due to subacromial impingement.36 Patients may feel 
their shoulder “catch” during abduction or flexion of the glenohumeral joint.  This 
dynamic impingement can arise from anatomic (coracohumeral ligament 
thickening, calcium deposition, acromial spurring) or functional (abnormal muscle 
firing pattern, weak scapular stabilizers) reasons.  Injury to or abnormal function of 
the rotator cuff muscles, which are dynamic stabilizers of the glenohumeral joint, 
will alter the positioning of the humeral head relative to the glenoid. Most 
commonly, the humerus will be more cephalad, which will decrease the subacromial 
space as the humerus flexes or abducts.  The larger and more powerful scapular 
rotators, including the trapezius, rhomboids, levator scapula, latissimus dorsi and 
serratus anterior, are active to varying amounts throughout scapulothoracic and 
glenohumeral overhead motion.37 If these muscles are not coordinated properly in 
their muscle firing pattern, acromial elevation will not be adequate as the humerus 
rotates, which may also lead to impingement symptoms.  If you combine functional 
decreased subacromial space with a calcific deposit in the rotator cuff, you are 
further reducing the space that tendons can move under the acromion without 
restriction.  Therefore, therapy should be directed at regaining optimal scapular 
mechanics, which will allow for better clearance of the supraspinatus tendon and 
subacromial bursa between the humeral head and anterior portion of the acromion.  
Beneficial exercises have been identified which preferentially activate the 
middle trapezius, lower trapezius and serratus anterior, with less activation of 
upper trapezius.38 These exercises can help restore proper balance of the scapular 
rotators. A well organized therapy program, starting from range of motion and 
flexibility exercises, progressing to closed-chain, then open-chain and finally sports 
specific exercises has been shown to lead to improved scapular mechanics and 
related shoulder pain.39 
Injections 
Various injections with differing techniques have been utilized in the 
management of RCCT.  An intrabursal injection of corticosteroid may be used if the 
patient has symptoms of subacromial impingement and bursitis.3 Other injection 
techniques attempt to address the calcium deposit more directly by breaking up and 
aspirating its contents. 
One study used fluoroscopy to help needle guidance during aspiration and 
lavage of calcium deposits.  They were able to aspirate calcium in 76% of the 
patients, and while calcium deposits were decreased in area at 2-month follow-up, 
no difference was seen between patients with positive or negative aspiration of 
calcium.40 Pain and range of motion were improved, although the authors 
questioned the clinical significance of the amount of range of motion gained. 
Multiple groups have investigated lavage techniques under real-time 
ultrasound guidance to aspirate portions of the calcium deposits.  These techniques 
may utilize two needles24,41,42 or one.43-48 The technique is often performed as 
follows (Fig. 3 and 4): 
Under ultrasound guidance, the needle is introduced in plane with 
the ultrasound beam, allowing visualization of the needle throughout its 
path to the calcium deposit. Most investigators stress puncturing the deposit 
once (or twice if using the two-needle technique), to maintain the integrity 
of the calcium deposit capsule and reduce calcium leakage.  In the single-
needle technique, once inside the calcium deposit, a small amount of fluid is 
injected and then pressure on the plunger is released to allow back flow of 
calcium deposit into the syringe. In the two-needle technique, the second 
needle aspirates the introduced fluid. Often, a cloudy fluid containing 
calcium will be removed.  This process is repeated until the aspirated fluid is 
clear and the calcium deposit appears smaller on ultrasound images.  Once 
aspirated fluid is clear, or if no cloudy fluid could be removed, the deposit is 
needled repeatedly in attempt to break up the remaining calcium deposit.  
At that point, the needle is either drawn back into the subacromial 
bursa, or is completely withdrawn and a new needle is inserted into the 
subacromial bursa. A corticosteroid injection, with local anesthetic, is then 
administered to prevent subsequent bursitis.  
 Farin was the first to describe outcomes when using ultrasound guidance to 
perform aspiration and lavage of calcium deposits. In their 2-needle technique, they 
punctured the deposit 10-15 times prior to injecting saline solution, followed by 
aspiration of the injected fluid with a second needle until no more calcium could be 
removed. Results were excellent in 73% of patients, and often correlated with 
decreased size of the deposit.49  
Another two-needle technique did not include the calcium puncture prior to 
the lavage portion of the procedure. This step was omitted to maintain the cavity as 
intact as possible, which was assumed to facilitate more effective calcium removal. 
They found improved pain using both the Constant and VAS scales in the treated 
compared to non-treated group at 1, 3, and 12 months post procedure, an effect that 
disappeared at 5- and 10-year follow-up.41 
In an attempt to achieve better calcium salt dissolution, Scofienza recently 
investigated the variable of saline temperature. They found shorter procedure time 
and easier dissolution of calcium deposits.42 VAS was not different between saline 
temperature groups, but bursitis incidence was less in warm saline treated patients.  
Other investigators utilize only a single needle, which further reduces the 
number of times the calcium cavity is violated.  Bradley et al presented a case report 
of 11 patients with RCCT treated with this technique. By two weeks post-procedure, 
10 of the patients had complete resolution of symptoms.43 The one patient with pain 
remaining had a concurrent supraspinatus tendon tear. 
Yoo presented data from 35 shoulders that were treated with needle 
decompression via a similar technique described above.  Twenty-five shoulders 
were almost pain free by 6 months post-procedure, and 22 experienced relief by 3 
months.47 Six of the patients needed to undergo arthroscopic removal due to 
persistent pain and were found to have rotator cuff defects at the time of surgery.  
Ciampi treated 50 patients with calcium deposit puncture prior to lavage and 
aspiration.  At 3-month follow up; pain was significantly improved when using the 
SPADI score, UCLA score and VAS scale.48 
At the Hospital for Special Surgery in New York, investigators retrospectively 
looked at 36 patients who had undergone either single or double needle aspiration 
followed by lavage for calcific tendinopathy. Both the NRS score and L’Insalata 
scores improved post-procedure, and 77.8% of the patients rated their level of 
satisfaction as “good”, “very good”, or “excellent”.50 Four patients ended up receiving 
surgical treatment after the procedure. 
One study investigated the difference between ESWT alone or with the 
addition of needling.  While both groups had improvement in Constant shoulder 
scores, the group who received ESWT and needling had better clinical improvement, 
radiologic disappearance of deposits, and less need for arthroscopic surgery.51 
One of the limitations of many of these studies is the lack of a control group.  
As is well documented, calcific tendinopathy is a dynamic process that is often self-
limiting and spontaneous resorption of the deposits may occur.  Comparing patients 
pre- and post-procedure is good to track, but without a control group, it is 
impossible to say how much of the benefit is due to the treatment chosen or to 
spontaneous improvement that would have occurred without any intervention. 
The specific technique used in these studies varied. A few important aspects 
were consistent between all of the studies: 
 Calcium deposit fragmentation 
 Lavage of calcium deposit with saline +/- lidocaine  
 Attempted aspiration of calcium.  
 Subacromial bursa injection to reduce the risk of post-procedure bursitis 
While calcium removal is the goal of these procedures, it can’t always be 
accomplished. Ultrasound and computed tomography images can help predict if 
calcific deposits will be hard and unable to aspirate or soft and able to remove 
calcium during needle treatment.24 The ability to aspirate calcium may be 
dependent on the phase of the calcification24,43,44, and deposit type might play a role 
in successful treatment.47 The ability to remove more calcium during the procedure 
does not result in better pain relief42 and a decrease in calcium deposit size is seen 
regardless of initial ability to remove all calcium from the deposit.43,45 Removal of 
calcium may not even be necessary to provide pain relief.52  
Conclusions 
 RCCT is a common finding in rotator cuff disease that can cause significant 
shoulder pain and disability. It usually presents as an acute tendonitis with 
subacromial impingement and bursitis. It can be seen easily with imaging studies 
such as x-ray, MRI, or ultrasound. Most patients respond favorably to conservative 
measures. NSAIDs, modalities, and subacromial bursa steroid injections can help 
manage pain. Physical therapy can help improve scapular mechanics and decrease 
subacromial impingement. Therapeutic ultrasound, ESWT and ultrasound-guided 
needle aspiration and lavage can reduce the size of the calcium deposit and lead to 
substantial long-term improvement in pain and function.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Summary Tables 
 
Table 1. Summary of different theories on pathogenesis of calcific tendinopathy 
Theory Proposed Mechanism 
Degenerative Calcification Intracellular calcium accumulated from old, 
damaged and necrotic tenocytes 
Reactive Calcification Metaplastic fibrocartilage with calcium 
deposited through an inflammatory mechanism  
Endochondral Ossification Metaplastic fibrocartilage becomes vascular 
from underlying bone marrow and calcium 
deposited without evidence of inflammation 
(Similar to bone spur formation) 
Chondral Metaplasia Erroneous differentiation of tenocytes into bone 
cells, mediated by BMP-2 
 
 
Table 2. Summary of different stages of calcific tendinopathy 
Stages of calcification Pathophysiology 
Pre-calcific stage Tenocytes undergo metaplasia into 
fibrocartilagenous tissue 
Calcific stage – formative phase Calcium crystals deposit onto metaplastic tissue  
Calcific stage – resorptive phase Phagocytosis of deposited calcium  
Post-calcific stage Remodeling of affected tissue  
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